These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12721905)

  • 21. Global measles and rubella laboratory network--update.
    World Health Organization
    Wkly Epidemiol Rec; 2005 Nov; 80(44):384-8. PubMed ID: 16300026
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparison of serological procedures used for the diagnosis of viral exanthema in laboratories participating in the measles elimination plan].
    de Ory F; Sanz JC; Echevarría JE; Mosquera Mdel M; Guisasola ME;
    Enferm Infecc Microbiol Clin; 2004; 22(6):319-22. PubMed ID: 15228897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can measles be eradicated globally?
    de Quadros CA
    Bull World Health Organ; 2004 Feb; 82(2):134-8. PubMed ID: 15042236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress toward interrupting indigenous measles transmission--Region of the Americas, January 1999-September 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(43):986-90. PubMed ID: 11098862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory diagnosis of measles infection and monitoring of measles immunization: memorandum from a WHO meeting.
    Bull World Health Organ; 1994; 72(2):207-11. PubMed ID: 8205639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of regional measles surveillance data in the Americas, 1996-99.
    Hersh BS; Tambini G; Nogueira AC; Carrasco P; de Quadros CA
    Lancet; 2000 Jun; 355(9219):1943-8. PubMed ID: 10859039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles eradication in the Americas: progress to date.
    de Quadros CA; Izurieta H; Venczel L; Carrasco P
    J Infect Dis; 2004 May; 189 Suppl 1():S227-35. PubMed ID: 15106116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The running status of Chinese Measles Laboratory Network in 2008].
    Zhang Y; Xu ST; Jiang XH
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):104-7. PubMed ID: 20077651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Microbiological Surveillance of Measles and Rubella in Spain. Laboratory Network].
    Echevarría JE; Fernández García A; de Ory F
    Rev Esp Salud Publica; 2015; 89(4):381-91. PubMed ID: 26580793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplex Bead Assay for the Serological Surveillance of Measles and Rubella.
    Coughlin MM; Smits G; Matson Z; van Binnendijk R; Bankamp B
    Methods Mol Biol; 2024; 2808():225-246. PubMed ID: 38743374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress toward measles elimination--region of the Americas, 2002-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(14):304-6. PubMed ID: 15085074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles and rubella eradication in the Americas.
    Andrus JK; de Quadros CA; Solórzano CC; Periago MR; Henderson DA
    Vaccine; 2011 Dec; 29 Suppl 4():D91-6. PubMed ID: 22185837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PAHO measles reference laboratory network.
    Bull Pan Am Health Organ; 1995 Sep; 29(3):276-8. PubMed ID: 8520613
    [No Abstract]   [Full Text] [Related]  

  • 35. Global distribution of measles genotypes and measles molecular epidemiology.
    Rota PA; Brown K; Mankertz A; Santibanez S; Shulga S; Muller CP; Hübschen JM; Siqueira M; Beirnes J; Ahmed H; Triki H; Al-Busaidy S; Dosseh A; Byabamazima C; Smit S; Akoua-Koffi C; Bwogi J; Bukenya H; Wairagkar N; Ramamurty N; Incomserb P; Pattamadilok S; Jee Y; Lim W; Xu W; Komase K; Takeda M; Tran T; Castillo-Solorzano C; Chenoweth P; Brown D; Mulders MN; Bellini WJ; Featherstone D
    J Infect Dis; 2011 Jul; 204 Suppl 1():S514-23. PubMed ID: 21666208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An indirect immunocolorimetric assay to detect rubella virus infected cells.
    Chen MH; Zhu Z; Zhang Y; Favors S; Xu WB; Featherstone DA; Icenogle JP
    J Virol Methods; 2007 Dec; 146(1-2):414-8. PubMed ID: 17919742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. History and prospects for viral disease eradication.
    de Quadros CA
    Med Microbiol Immunol; 2002 Oct; 191(2):75-81. PubMed ID: 12410345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles and rubella elimination initiatives in the Americas: lessons learned and best practices.
    Castillo-Solorzano C; Marsigli C; Danovaro-Holliday MC; Ruiz-Matus C; Tambini G; Andrus JK
    J Infect Dis; 2011 Jul; 204 Suppl 1():S279-83. PubMed ID: 21666173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles elimination in Italy: data from laboratory activity, 2011-2013.
    Magurano F; Baggieri M; Fortuna C; Bella A; Filia A; Rota MC; Benedetti E; Bucci P; Marchi A; Nicoletti L
    J Clin Virol; 2015 Mar; 64():34-9. PubMed ID: 25728076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic algorithm for the confirmation of cases of measles and rubella in Mexico.
    Román-Pedroza JF; Cruz-Ramírez E; Landín-Martínez KE; Salas-García M; López-Ortiz E; Ramírez-González JE; López-Martínez I; Díaz-Quiñonez JA
    Gac Med Mex; 2019; 155(5):492-495. PubMed ID: 32091024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.